12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ItMSCs: Phase II data

A double-blind Phase II trial in 45 patients who experienced an acute MI and underwent reperfusion by stent showed that IV itMSCs given on day 7 improved LVEF by 11 points vs. placebo. Additionally,...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >